What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer of RNA-based therapies, continued a slide that began just ahead of the weekend.
Keep Reading →
April 2 - Market Movers, News - Comments
"The S&P 500 and the Nasdaq Composite hit fresh intraday records on Monday as a jump in oil prices to a two-week high lifted Wall Street sentiment.
Keep Reading →
May 15 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we ...
Keep Reading →
March 16 - Hedge Funds, News - Comments
U.S indexes have opened lower this morning, as the trading week has kicked off with a plunge in global bonds courtesy of inflation fears.
Keep Reading →
October 17 - Insider Trading, News - Comments
A couple of companies have had a tough twenty-four hours in the biotech space.
Keep Reading →
October 7 - News, Stock Analysis - Comments
Many traders are watching crude futures today to see if WTI can break out of the $50 per barrel mark.
Keep Reading →
October 6 - Market Movers, News - Comments
Bridger Management, led by Roberto Mignone, has filed its 13F with the SEC for the current reporting period.
Keep Reading →
August 18 - Hedge Fund Analysis, Hedge Funds, News - Comments
For the latest deal, Biogen Idec Inc (NASDAQ:BIIB) is giving Isis $100 million up front, and ISIS Pharmaceuticals, Inc.
Keep Reading →
September 11 - News - Comments
The health care sector has been one of the best performing sectors of 2013.
Keep Reading →
September 11 - News - Comments
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Keep Reading →
August 28 - News - Comments
Now, according to many market players, hedge funds are viewed as delayed, outdated financial tools of an era lost to time.
Keep Reading →
August 22 - News - Comments
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Keep Reading →
August 22 - News - Comments
Once upon a time in a regulatory environment far, far away, there was a cholesterol-fighting drug named Lipitor from Pfizer Inc. (NYSE:PFE).
Keep Reading →
August 21 - News - Comments
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Keep Reading →
August 6 - News - Comments
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Keep Reading →
August 6 - News - Comments
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), already quite expensive, spiked higher since takeover rumors surfaced in early July.
Keep Reading →
August 6 - News - Comments
In 2013, a number of new drugs got approvals from the FDA. This provided a boost to the biotech industry as a whole.
Keep Reading →
August 5 - News - Comments
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Keep Reading →
July 22 - News - Comments
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year.
Keep Reading →
July 16 - News - Comments
If you thought the fireworks ended after the Fourth of July celebrations last week, think again.
Keep Reading →
July 15 - News - Comments
Biotech's the biggest boom-or-bust business on the market, with regulatory approvals and clinical trial results routinely sending stocks hurtling up or down by significant amounts...
Keep Reading →
July 15 - News - Comments
With the SPDR S&P Biotech Index up 33% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 15 - News - Comments
RNAi and RNA companies had a terrible time when they were abandoned by big pharmaceutical companies.
Keep Reading →
July 10 - News - Comments
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 8 - News - Comments
While many American skies were lit up with fireworks this week, the stock market also saw its share of pops, sizzles, and bangs.
Keep Reading →
July 8 - News - Comments
Shares of biotech Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) have soared over 160% in the past year.
Keep Reading →
June 20 - News - Comments
About a third of American adults have high LDL cholesterol -- that's the bad kind -- but less than half of adults with high LDL seek treatment, according to the Centers for Disease...
Keep Reading →
June 18 - News - Comments
To most traders, hedge funds are assumed to be unimportant, old investment vehicles of years past.
Keep Reading →
June 11 - News - Comments
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 10 - News - Comments
Small biotech companies have great investment potential if you can identify them properly.
Keep Reading →
April 24 - News - Comments
"There are many reasons for an insider to sell a stock, but only one to buy it: he expects to make money." So goes the saying.
Keep Reading →
March 7 - News - Comments
I have reviewed over 80 stocks as investment opportunities.
Keep Reading →
March 6 - News - Comments
